These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14035317)

  • 1. [On the immunological reactivity at remote periods of workers in meat-packing plants vaccinated against brucellosis].
    KOZLOV MP
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Nov; 33():43-7. PubMed ID: 14035317
    [No Abstract]   [Full Text] [Related]  

  • 2. Brucellosis vaccines for livestock.
    Goodwin ZI; Pascual DW
    Vet Immunol Immunopathol; 2016 Nov; 181():51-58. PubMed ID: 27032465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological reconstruction in persons repeatedly vaccinated against brucellosis in foci of infection].
    Zemel'man BM; Bessmertnaia FS
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Sep; 42(9):78-81. PubMed ID: 4224675
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
    Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lymphoblastic transformation by fractions of Brucella in patients having had brucellosis and subjects vaccinated by the vaccine PI].
    Peraldi M; Lopez A; Lacave C; Bascoul S; Serre A
    Dev Biol Stand; 1976; 31():157-64. PubMed ID: 1261734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aerosol immunization with dry powder vaccines and anatoxins. IX] [Further study of the reactivity and immunological effectiveness of the method of aerosol immunization by dried brucellosis vaccine].
    ALEKSANDROV NI; GEFEN NE; GAPOCHKO KG; GARIK NS; MASLOV AI; MISCHENKO VV; SMIRNOV MS
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Dec; 33():95-102. PubMed ID: 14041501
    [No Abstract]   [Full Text] [Related]  

  • 8. [CLINICAL ASPECTS OF BRUCELLOSIS IN VACCINATED SUBJECTS].
    MADZHIDOV VM
    Sov Med; 1964 Dec; 27():80-3. PubMed ID: 14329064
    [No Abstract]   [Full Text] [Related]  

  • 9. Brucellosis: Improved Diagnostics and Vaccine Insights from Synthetic Glycans.
    Bundle DR; McGiven J
    Acc Chem Res; 2017 Dec; 50(12):2958-2967. PubMed ID: 29219305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [IMMUNOLOGICAL EFFECTIVENESS OF VACCINATION AGAINST BRUCELLOSIS].
    KASIANENKO AM
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Aug; 40():39-44. PubMed ID: 14091796
    [No Abstract]   [Full Text] [Related]  

  • 11. Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections.
    Zhu L; Feng Y; Zhang G; Jiang H; Zhang Z; Wang N; Ding J; Suo X
    Vaccine; 2016 Jan; 34(3):395-400. PubMed ID: 26626213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgE anti-brucella antibodies in the course of human brucellosis and after specific vaccination.
    Escande A; Serre A
    Int Arch Allergy Appl Immunol; 1982; 68(2):172-5. PubMed ID: 7076328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs].
    Bolpe J; de Lapenta DF; García-Carrillo C
    Rev Inst Med Trop Sao Paulo; 1991; 33(1):23-7. PubMed ID: 1843392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenic and protective antigens of Brucella as vaccine candidates.
    Masjedian Jezi F; Razavi S; Mirnejad R; Zamani K
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():29-36. PubMed ID: 31300122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immuno-stimulating effect of levamisole in the immunization of guinea pigs vaccinated against brucellosis].
    Sandoval LA; Giorgi W; Amaral LB; Zampolli E; Manzati MT
    Arq Inst Biol (Sao Paulo); 1978; 45(4):313-7. PubMed ID: 754679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunity against brucellosis in reindeer vaccinated with vaccine of strain 19].
    Davydov NN; Lyskov AV
    Veterinariia; 1967 Sep; 44(9):57-61. PubMed ID: 5629629
    [No Abstract]   [Full Text] [Related]  

  • 17. Ovine brucellosis: repeated vaccination with Rev 1 vaccine and the prevalence of the disease in the Winburg district.
    Erasmus JA; Bergh EC
    J S Afr Vet Assoc; 1985 Dec; 56(4):205-8. PubMed ID: 3836306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CURRENT ADVANCES IN BRUCELLOSIS RESEARCH.
    MANTHEI CA
    Public Health Rep (1896); 1964 Dec; 79(12):1074-80. PubMed ID: 14234348
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epicutaneous revaccination against brucellosis of workers in meat-packing plants and in animal husbandry establishments].
    VERSHILOVA PA; GOLUBEVA AA
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Mar; 29(3):58-62. PubMed ID: 13570443
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and trial of vaccines against
    Lalsiamthara J; Lee JH
    J Vet Sci; 2017 Aug; 18(S1):281-290. PubMed ID: 28859268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.